Cytokines levels, Severity of acute mucositis and the need of PEG tube installation during chemo-radiation for head and neck cancer - a prospective pilot study
Creators
- 1. Department of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem (Israel)
- 2. School of Dental Medicine, Hadassah-Hebrew University, Jerusalem (Israel)
- 3. Division of Oncology, Rambam Health Care Campus and Faculty of Medicine, Technion-Israel Institute of Technology, Haifa (Israel)
- 4. Department of Maxillofacial Prosthetics, Hadassah-Hebrew University Medical Center, Jerusalem (Israel)
Description
The purpose of this pilot study was to detect a correlation between serum cytokine levels and severity of mucositis, necessitating installation of a percutaneous endoscopic gastrostomy tube (PEG) in head and neck (H&N) cancer patients receiving combined chemo-radiation therapy. Fifteen patients with H&N epithelial cancer were recruited to this study. All patients received radiotherapy to the H&N region, with doses ranging from 50-70 Gy. Chemotherapy with cisplatin, carboplatin, 5-fluorouracil and taxanes was given to high-risk patients, using standard chemotherapy protocols. Patients were evaluated for mucositis according to WHO common toxicity criteria, and blood samples were drawn for inflammatory (IL-1, IL-6, IL-8, TNF-α) and anti-inflammatory (IL-10) cytokine levels before and during treatment. A positive correlation was found between IL-6 serum levels and severity of mucositis and dysphagia; specifically, high IL-6 levels at week 2 were correlated with a need for PEG tube installation. A seemingly contradictory correlation was found between low IL-8 serum levels and a need for a PEG tube. These preliminary results, indicating a correlation between IL-6 and IL-8 serum levels and severity of mucositis and a need for a PEG tube installation, justify a large scale study
Availability note (English)
Available from http://dx.doi.org/10.1186/1748-717X-5-16; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837669Additional details
Identifiers
Publishing Information
- Journal Title
- Radiation Oncology (Online)
- Journal Volume
- 5
- Journal Page Range
- p. 16
- ISSN
- 1748-717X
INIS
- Country of Publication
- United Kingdom
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 47029411
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- CHEMOTHERAPY; CORRELATIONS; HEAD; INSTALLATION; LYMPHOKINES; NECK; NEOPLASMS; PATIENTS; TUBES; URACILS
- Descriptors DEC
- AZINES; BODY; DISEASES; GROWTH FACTORS; HETEROCYCLIC COMPOUNDS; HYDROXY COMPOUNDS; MEDICINE; MITOGENS; ORGANIC COMPOUNDS; ORGANIC NITROGEN COMPOUNDS; PROTEINS; PYRIMIDINES; THERAPY
Optional Information
- Copyright
- Copyright (c)2010 Meirovitz et al
- Notes
- PMCID: PMC2837669; PUBLISHER-ID: 1748-717X-5-16; PMID: 20184737; OAI: oai:pubmedcentral.nih.gov:2837669; licensee BioMed Central Ltd.